124643-35-2 Usage
Description
C20H27F3O4S, also known as Prasterone Triflate, is a derivative of Prasterone (D229585), which is a major secretory steroidal product of the adrenal gland. It is a chemical compound with a molecular structure consisting of 20 carbon atoms, 27 hydrogen atoms, 3 fluorine atoms, 4 oxygen atoms, and 1 sulfur atom.
Uses
1. Used in Pharmaceutical Industry:
C20H27F3O4S is used as a pharmaceutical compound for its potential therapeutic applications. As a derivative of Prasterone, it may have similar or enhanced effects on various physiological processes, making it a candidate for the development of new drugs or treatments.
2. Used in Research and Development:
C20H27F3O4S can be utilized in research and development for understanding the structure-activity relationship of steroidal compounds and their potential applications in medicine. Its unique molecular structure may provide insights into the design of new drugs with improved efficacy and reduced side effects.
3. Used in Drug Delivery Systems:
Similar to Gallotannin, C20H27F3O4S could potentially be incorporated into drug delivery systems to enhance its bioavailability, targeting, and therapeutic outcomes. The development of novel drug delivery systems, such as organic and metallic nanoparticles, could improve the delivery and efficacy of this compound in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 124643-35-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,6,4 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 124643-35:
(8*1)+(7*2)+(6*4)+(5*6)+(4*4)+(3*3)+(2*3)+(1*5)=112
112 % 10 = 2
So 124643-35-2 is a valid CAS Registry Number.
124643-35-2Relevant articles and documents
PROCESS FOR THE PREPARATION OF ABIRATERONE AND INTERMEDIATES THEREOF
-
Paragraph 0134; 0135, (2015/02/05)
The present invention provides intermediates for preparing abiraterone, and processes for preparing abiraterone and intermediates thereof. The intermediates include a compound of formula (IV): wherein R represents a hydroxy-protecting group.
